Hexoprenaline Sulfate

硫酸海索那林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHexoprenaline Sulfate
Drug Alias Namehexoprenalinum硫酸己双肾上腺素hexoprenalinaIpradolArgocian +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeR03AC06R03CC05
Related LinksWikipediaDrugBankKEGG